Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study
European journal of clinical pharmacology(2023)
Key words
Anti-angiogenic agent,Docetaxel,Immune checkpoint inhibitors,Non-small cell lung cancer,Ramucirumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined